drugset / Trial / NCT06927258

Application of Changyanning Granule in Endoscopic Resection of Colorectal Polyps

NCT06927258 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the efficacy of Chanyanning granules in patients undergoing endoscopic resection of colorectal polyps with a basal diameter of 5-30 mm. From one day before the procedure to five days postoperatively, patients will be administered Chanyanning granules. The study will observe intraoperative and postoperative bleeding, perforation, and digestive system-related clinical symptoms such as postoperative abdominal pain, bloating, diarrhea, constipation, hematochezia, and fatigue, as well as related inflammatory markers, to determine the therapeutic effect of Chanyanning granules.

Timeline

Start
2024-11-01
Primary completion
2025-09-01
Completion
2026-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator changyanning granules Unknown — —

Indications